Addex Therapeutics (ADXN) is scheduled to report Q4 earnings on April 24, 2026.
Over the last 2 quarters, Addex Therapeutics has averaged an EPS surprise of 0.19% and a revenue surprise of 2261538.48%.
Analyze the earnings history of Addex Therapeutics using advanced sorting and filters.
The chart below shows Addex Therapeutics's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Addex Therapeutics's reported revenue compared to analyst estimates over recent quarters.
Addex Therapeutics (ADXN) is scheduled to report earnings on April 24, 2026. The last reported earnings were for reported on December 4, 2025 for Q3.
The Actual EPS was $-1.50, which missed the estimate of $0.00.
The Actual Revenue was $62.50K, which beat the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2021-11-04 | $-14.40 | $-14.40 | 0.00 % |
| Q2 | 2021-08-05 | $-18.00 | $-13.00 | -38.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-09-30 | $127.15K | $ | -51.1 % |
| Q3 | 2023-11-29 | $370.87K | $700.00K | -47.0 % |
| Q3 | 2021-11-04 | $825.37K | $420.00K | 96.5 % |
| Q2 | 2021-08-05 | $1.18M | $260.00K | 452307600.0 % |